Quinn Opportunity Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-107,000
| Closed | -$1.32M | – | 468 |
|
|
2024
Q4 | $1.32M | Hold |
107,000
| – | – | 0.09% | 177 |
|
|
2024
Q3 | $1.22M | Sell |
107,000
-41,172
| -28% | -$413K | 0.12% | 137 |
|
|
2024
Q2 | $1.06M | Sell |
148,172
-9,000
| -6% | -$68.8K | 0.12% | 127 |
|
|
2024
Q1 | $1.05M | Buy |
157,172
+30,380
| +24% | +$209K | 0.12% | 133 |
|
|
2023
Q4 | $824K | Buy |
126,792
+108,762
| +603% | +$701K | 0.09% | 135 |
|
|
2023
Q3 | $170K | Hold |
18,030
| – | – | 0.02% | 204 |
|
|
2023
Q2 | $252K | Hold |
18,030
| – | – | 0.03% | 174 |
|
|
2023
Q1 | $338K | Sell |
18,030
-2,000
| -10% | -$32.9K | 0.03% | 185 |
|
|
2022
Q4 | $276K | Hold |
20,030
| – | – | 0.03% | 152 |
|
|
2022
Q3 | $383K | Sell |
20,030
-2,970
| -13% | -$54.1K | 0.04% | 141 |
|
|
2022
Q2 | $351K | Hold |
23,000
| – | – | 0.03% | 159 |
|
|
2022
Q1 | $469K | Hold |
23,000
| – | – | 0.02% | 133 |
|
|
2021
Q4 | $671K | Sell |
23,000
-9,000
| -28% | -$258K | 0.04% | 153 |
|
|
2021
Q3 | $690K | Sell |
32,000
-2,000
| -6% | -$48.3K | 0.04% | 178 |
|
|
2021
Q2 | $872K | Sell |
34,000
-2,000
| -6% | -$42.7K | 0.05% | 164 |
|
|
2021
Q1 | $656K | Sell |
36,000
-5,745
| -14% | -$95.5K | 0.04% | 173 |
|
|
2020
Q4 | $482K | Hold |
41,745
| – | – | 0.04% | 170 |
|
|
2020
Q3 | $318K | Sell |
41,745
-43,100
| -51% | -$326K | 0.03% | 157 |
|
|
2020
Q2 | $557K | Sell |
84,845
-3,155
| -4% | -$17.6K | 0.07% | 127 |
|
|
2020
Q1 | $450K | Sell |
88,000
-22,000
| -20% | -$133K | 0.07% | 116 |
|
|
2019
Q4 | $844K | Hold |
110,000
| – | – | 0.1% | 103 |
|
|
2019
Q3 | $583K | Sell |
110,000
-42,000
| -28% | -$261K | 0.07% | 114 |
|
|
2019
Q2 | $851K | Hold |
152,000
| – | – | 0.11% | 98 |
|
|
2019
Q1 | $646K | Buy |
152,000
+2,000
| +1% | +$8.16K | 0.09% | 107 |
|
|
2018
Q4 | $615K | Hold |
150,000
| – | – | 0.09% | 91 |
|
|
2018
Q3 | $1.03M | Buy |
150,000
+6,500
| +5% | +$38.5K | 0.15% | 87 |
|
|
2018
Q2 | $563K | Buy |
143,500
+20,000
| +16% | +$69.4K | 0.07% | 118 |
|
|
2018
Q1 | $361K | Buy |
123,500
+31,500
| +34% | +$97.3K | 0.05% | 144 |
|
|
2017
Q4 | $357K | Buy |
92,000
+29,900
| +48% | +$128K | 0.06% | 135 |
|
|
2017
Q3 | $195K | Buy |
+62,100
| New | +$233K | 0.03% | 195 |
|
Other funds holding CDMO
Quinn Opportunity Partners's CDMO Position: Q1 2025 in Review
Quinn Opportunity Partners sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 107,000 shares — an estimated $1.32M sold.
Quinn Opportunity Partners first reported a position in CDMO in Q3 2017 and held it in 30 quarters. The position peaked at $1.32M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Quinn Opportunity Partners reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Quinn Opportunity Partners sold 107,000 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.32M.
- Quinn Opportunity Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2017 and held it in 30 quarters.
- Quinn Opportunity Partners's Avid Bioservices, Inc. Common Stock position peaked at $1.32M in Q4 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Quinn Opportunity Partners's 13F filing for Q1 2025, filed 14 May 2025.